S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

NGM NGM Biopharmaceuticals Inc

1.54

0.00 (0.00%)

24 Jan 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals Inc News

NGM Bio Announces Closing of Tender Offer
Saturday 6 April 2024 (10 months ago) • GlobeNewswire Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Wednesday 20 March 2024 (10 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 12 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 March 2024 (10 months ago) • Edgar (US Regulatory)

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
Tuesday 12 March 2024 (10 months ago) • GlobeNewswire Inc.

Form SC 13E3 - Going private transaction by certain issuers
Saturday 9 March 2024 (11 months ago) • Edgar (US Regulatory)

Form SC 14D9 - Solicitation, recommendation statements
Saturday 9 March 2024 (11 months ago) • Edgar (US Regulatory)

Form SC14D9C - Written communication relating to third party tender offer
Tuesday 27 February 2024 (11 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (11 months ago) • Edgar (US Regulatory)

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
Tuesday 27 February 2024 (11 months ago) • GlobeNewswire Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
Wednesday 21 February 2024 (11 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (11 months ago) • Edgar (US Regulatory)

More NGM Biopharmaceuticals Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions